Circulating Leukocyte as an Inflammatory Biomarker: Association with Fibrinogen and Neuronal Damage in Acute Ischemic Stroke

Background and Purpose Leukocytes and fibrinogen are inflammatory markers involved in circulating and central inflammatory response after ischemic stroke. However, the interaction between circulating leukocytes and serum fibrinogen and neuronal injury in acute ischemic stroke (AIS) patients is still unclear. The present study aimed to investigate the association between circulating leukocyte and serum fibrinogen and neuronal injury respectively in AIS. Methods A cross-section study with 431 hospitalized AIS patients from department of neurology was performed. Circulating leukocytes and fibrinogen were measured, and neuron-specific enolase (NSE) was detected to evaluate central neuronal damage. A propensity score matching method was used to minimize the effects of confounding factors. The relationship between leukocytes and NSE and fibrinogen was analyzed by linear curve fitting analysis and multiple logistic regression models respectively. Results The mean levels of NSE, leukocyte, and fibrinogen were significantly higher in the matched AIS group (n=89) than those of in the healthy control group (n=89) (all p<0.05). Both serum NSE and fibrinogen were increased with the increasing of leukocyte in AIS patients (both p<0.05). Smoothed plots suggested that there are linear relationships between leukocyte and NSE and fibrinogen respectively. Multiple logistic regression analysis showed the OR (95%) for the relationship between leukocyte and high NSE were 1.13 (1.01–1.26, p=0.031) and 1.13 (1.00–1.28, p=0.048), and between leukocyte and high fibrinogen were 1.40 (1.22–1.61, p<0.001) and 1.35 (1.15–1.58, p<0.001) in all AIS patients before and after adjusting for potential confounders. Conclusion Our study suggests that elevated circulating leukocyte was associated with high fibrinogen and neuronal injury in AIS. Therefore, there may be potential targets among circulating leukocyte, fibrinogen and NSE that should be intervened to reduce inflammatory reaction after ischemic stroke.

[1]  F. Montecucco,et al.  Inflammatory biomarkers of ischemic stroke , 2023, Internal and Emergency Medicine.

[2]  Feng Yan,et al.  Prevalence of stroke in China, 2013–2019: A population-based study , 2022, The Lancet regional health. Western Pacific.

[3]  Kevin D. Moss,et al.  Fibrin is a critical regulator of neutrophil effector function at the oral mucosal barrier , 2021, Science.

[4]  N. Nielsen,et al.  Neuron-Specific Enolase and long-term neurological outcome after OHCA - a validation study. , 2021, Resuscitation.

[5]  F. Marofi,et al.  Matrix metalloproteinases are involved in the development of neurological complications in patients with Coronavirus disease 2019 , 2021, International Immunopharmacology.

[6]  Zhan Gao,et al.  Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study , 2021, Cardiovascular Diabetology.

[7]  Batool F. Kirmani,et al.  Acute Stroke Management: Overview and Recent Updates , 2021, Aging and disease.

[8]  P. Libby,et al.  TNF‐α antagonism rescues the effect of ageing on stroke: Perspectives for targeting inflamm‐ageing , 2021, European journal of clinical investigation.

[9]  S. Massberg,et al.  Interplay between inflammation and thrombosis in cardiovascular pathology , 2021, Nature Reviews Cardiology.

[10]  Yongjun Wang,et al.  The lymphatic drainage system of the CNS plays a role in lymphatic drainage, immunity, and neuroinflammation in stroke , 2021, Journal of leukocyte biology.

[11]  F. Montecucco,et al.  Cytokines as therapeutic targets for cardio- and cerebrovascular diseases , 2021, Basic Research in Cardiology.

[12]  Ranran Wang,et al.  Neutrophil extracellular traps promote tPA-induced brain hemorrhage via cGAS in mice with stroke , 2021, Blood.

[13]  Zhanli Qu,et al.  Plasma D-dimer level is associated with clinical outcomes in patients with atrial fibrillation related acute ischemic stroke after pneumonia , 2020, BMC Neurology.

[14]  A. Słowik,et al.  Prognostic Significance of Stroke-Associated Infection and other Readily Available Parameters in Acute Ischemic Stroke Treated by Intravenous Thrombolysis. , 2020, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[15]  T. Wijeratne,et al.  Acute Ischemic Stroke in COVID-19: A Case-Based Systematic Review , 2020, Frontiers in Neurology.

[16]  P. Libby,et al.  Postischemic Administration of IL-1α Neutralizing Antibody Reduces Brain Damage and Neurological Deficit in Experimental Stroke. , 2020, Circulation.

[17]  Yongjun Cao,et al.  Dynamic Changes in Fibrinogen and Prognosis of Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis , 2020, Neurotoxicity Research.

[18]  Xin Gao,et al.  Prognostic Value of Blood-Based Inflammatory Biomarkers in Secondary Hemophagocytic Lymphohistiocytosis , 2020, Journal of Clinical Immunology.

[19]  Jie Ding,et al.  Red blood cell distribution width is associated with neuronal damage in acute ischemic stroke , 2020, Aging.

[20]  U. de Faire,et al.  Physical activity attenuates cardiovascular risk and mortality in men and women with and without the metabolic syndrome - a 20-year follow-up of a population-based cohort of 60-year-olds. , 2020, European journal of preventive cardiology.

[21]  M. Hennus,et al.  Signal inhibitory receptor on leukocytes (SIRL)-1 and leukocyte- associated immunoglobulin-like receptor (LAIR)-1 regulate neutrophil function in infants. , 2019, Clinical immunology.

[22]  M. Lawton,et al.  Global brain inflammation in stroke , 2019, The Lancet Neurology.

[23]  V. Pettilä,et al.  Usefulness of neuron specific enolase in prognostication after cardiac arrest: Impact of age and time to ROSC. , 2019, Resuscitation.

[24]  J. Luyendyk,et al.  The multifaceted role of fibrinogen in tissue injury and inflammation. , 2019, Blood.

[25]  W. Hacke,et al.  Standards of practice in acute ischemic stroke intervention: international recommendations , 2018, Journal of NeuroInterventional Surgery.

[26]  Lingyun Sun,et al.  Citrullinated fibrinogen impairs immunomodulatory function of bone marrow mesenchymal stem cells by triggering toll-like receptor. , 2018, Clinical immunology.

[27]  Lee Kissel,et al.  Immune responses in stroke: how the immune system contributes to damage and healing after stroke and how this knowledge could be translated to better cures? , 2018, Immunology.

[28]  N. Banik,et al.  New Insights into the Role of Neuron-Specific Enolase in Neuro-Inflammation, Neurodegeneration, and Neuroprotection , 2018, Brain sciences.

[29]  Jang Mi Baek,et al.  Inflammatory mediator expression within retrieved clots in acute ischemic stroke , 2018, Annals of clinical and translational neurology.

[30]  D. Zheng,et al.  Hyperfibrinogenemia is Significantly Associated with an Increased Risk of In-hospital Mortality in Acute Ischemic Stroke Patients. , 2017, Current neurovascular research.

[31]  J. Froehlich,et al.  Fibrin(ogen) drives repair after acetaminophen-induced liver injury via leukocyte αMβ2 integrin-dependent upregulation of Mmp12. , 2017, Journal of hepatology.

[32]  L. L. Klimenko,et al.  Serum trace elements are associated with hemostasis, lipid spectrum and inflammatory markers in men suffering from acute ischemic stroke , 2017, Metabolic Brain Disease.

[33]  X. Ji,et al.  Serum neuron specific enolase may be a marker to predict the severity and outcome of cerebral venous thrombosis , 2017, Journal of Neurology.

[34]  J. E. Lee,et al.  Inflammation after Ischemic Stroke: The Role of Leukocytes and Glial Cells , 2016, Experimental neurobiology.

[35]  H. Hirai,et al.  Inflammation-induced reversible switch of the neuron-specific enolase promoter from Purkinje neurons to Bergmann glia , 2016, Scientific Reports.

[36]  H. Milionis,et al.  Prospective evaluation of postimplantation syndrome evolution on patient outcomes after endovascular aneurysm repair for abdominal aortic aneurysm. , 2016, Journal of Vascular Surgery.

[37]  R. Serra,et al.  Hemorrhoids and matrix metalloproteinases: A multicenter study on the predictive role of biomarkers. , 2016, Surgery.

[38]  Guohong Li,et al.  Role of Inflammation and Its Mediators in Acute Ischemic Stroke , 2013, Journal of Cardiovascular Translational Research.

[39]  Xiaodong Wang,et al.  Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation , 2013, Nature Medicine.

[40]  C. Sudlow,et al.  Association of Circulating Inflammatory Markers With Recurrent Vascular Events After Stroke: A Prospective Cohort Study , 2011, Stroke.

[41]  Guohong Li,et al.  Inflammatory mechanisms in ischemic stroke: role of inflammatory cells , 2010, Journal of leukocyte biology.

[42]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[43]  A. Demchuk,et al.  Hyperfibrinogenemia and functional outcome from acute ischemic stroke. , 2009, Stroke.

[44]  S. Vieira,et al.  Serum neuron-specific enolase as early predictor of outcome after in-hospital cardiac arrest: a cohort study , 2006, Critical care.

[45]  T. Odrljin,et al.  Integrin α v β 3-Mediated Endocytosis of Immobilized Fibrinogen by A549 Lung Alveolar Epithelial Cells , 2001 .

[46]  T. Odrljin,et al.  Integrin alphavbeta3-mediated endocytosis of immobilized fibrinogen by A549 lung alveolar epithelial cells. , 2001, American journal of respiratory cell and molecular biology.

[47]  M. Wiesmann,et al.  S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. , 1997, Stroke.